SECsense Logo

Assembly Biosciences, Inc. 8-K Report: Key Insights from February 20, 2025 Filing

$ASMB
Form 8-K
Filed on: 2025-02-20
Source
Assembly Biosciences, Inc. 8-K Report: Key Insights from February 20, 2025 Filing

Based on the provided XML snippet from the financial report, here are the key pieces of information extracted:

  1. Company Information:
  • Name: Assembly Biosciences, Inc.
  • Entity Identifier: CIK (Central Index Key) - 0001426800
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-35005
  • EIN: 20-8729264
  • Address: Two Tower Place, 7th Floor, South San Francisco, CA 94080
  • Phone Number: (833) 509-4583
  1. Filing Information:
  • Form Type: 8-K (Current Report)
  • Filing Date: February 20, 2025
  1. Stock Information:
  • Common Stock Par Value: $0.001
  • Stock Symbol: ASMB
  • Exchange: NASDAQ
  1. Reporting Dates:
  • Period Start Date: February 20, 2025
  • Period End Date: February 20, 2025

Insights:

  • The company is making a significant filing (8-K) which generally indicates a major event or corporate change that shareholders should be aware of.
  • The filing is dated for the same day as the reporting period, suggesting that the report may contain timely and relevant information pertaining to events occurring on that date.
  • Assembly Biosciences, Inc. is a publicly traded company on NASDAQ, indicating it is subject to SEC regulations and requirements for transparency and reporting.

This information can be critical for investors, analysts, and stakeholders who are looking to understand the company's current status, recent developments, and any potential impact on the stock price or business operations.